[The effect of percutaneous coronary intervention in women with ischaemic heart disease]

Lene Holmvang1, Hans Mickley

  • 1Rigshospitalet, Hjertemedicinsk Klinik B. lene.holmvang@dadlnet.dk

Ugeskrift for Laeger
|June 28, 2007
PubMed

Insights

Percutaneous coronary intervention (PCI) eases stable angina symptoms but doesn't improve long-term outcomes. While historically linked to higher complication rates in women, recent data show fewer gender disparities in PCI effectiveness for acute coronary syndromes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Percutaneous coronary intervention (PCI) is a common treatment for coronary artery disease.
  • Previous studies suggested higher complication rates for women undergoing PCI.
  • The prognostic impact and gender-specific outcomes of PCI require ongoing evaluation.

Purpose of the Study:

  • To evaluate the effectiveness of PCI in reducing symptoms for stable angina pectoris.
  • To assess gender differences in procedural complications and treatment benefits associated with PCI.
  • To examine the role of PCI in acute coronary syndromes, including ST-segment elevation myocardial infarction (STEMI) and non-STEMI.

Main Methods:

  • Review of clinical trial data comparing PCI outcomes in men and women.
  • Analysis of symptom reduction and prognostic impact of PCI in stable angina.
  • Evaluation of gender-specific benefits of primary PCI in STEMI.
  • Assessment of routine early invasive strategies for women with unstable angina and non-STEMI.

Main Results:

  • PCI effectively reduces symptoms in stable angina but does not improve prognosis.
  • Earlier trials showed higher PCI complication rates in women, but recent studies indicate diminished gender differences.
  • No significant gender differences were observed in the benefit of primary PCI for STEMI.
  • Women with unstable angina and non-STEMI may not benefit as much from routine early invasive PCI compared to men.

Conclusions:

  • PCI is beneficial for symptom management in stable angina, independent of gender in recent studies.
  • While effective for STEMI, women may derive less benefit from early invasive strategies in non-STEMI and unstable angina compared to men.
  • Further research is needed to optimize invasive treatment strategies for women with specific coronary syndromes.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...